Opening up the blindness of evidence-based medicine research on Shensong Yangxin capsule of Yiling pharmaceutical
-
Last Update: 2014-08-18
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The results showed that: compared with the placebo group (233 cases), Shensong Yangxin Capsule could significantly increase the decrease rate of ventricular premature times in 24-hour Holter, improve heart function and increase left ventricular ejection fraction There was significant difference between the treatment group and the control group in the analysis of 6-minute walking distance Shensong Yangxin capsule is a scientific and technological traditional Chinese medicine developed and produced by Yiling Pharmaceutical Co., Ltd in Hebei Province The evidence-based medicine has been proved to have the effects of integrated regulation, fast and slow treatment of arrhythmia, and has won the second prize of 2009 National Science and technology progress award.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
